Organoids & 3D modelsconfirmed

Parallel Bio

Human lymph node immune organoids, scaled with robotics and AI, to model immune response across donor populations.

Notable

Reported eight pharma partners at the Series A.

Jun 2025
Venture financing, Series A
Series A to scale its immune organoid platform; eight pharma partners reported.
$21M
synapse.patsnap.com(opens in new tab)

No related news yet.